查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014904

抽脂手術市場：按類型、方法、應用部位、最終用戶和性別分類－2026年至2032年全球市場預測

Liposuction Surgical Procedures Market by Type, Technique, Application Area, End User, Gender - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，抽脂手術市場價值將達到 18.2 億美元，到 2026 年將成長到 19.2 億美元，到 2032 年將達到 28.7 億美元，複合年成長率為 6.73%。

主要市場統計數據
基準年 2025 18.2億美元
預計年份：2026年 19.2億美元
預測年份 2032 28.7億美元
複合年成長率 (%) 6.73%

對現代抽脂術實踐進行全面概述，闡明方法、臨床因素和相關人員的決策因素。

抽脂手術正在迅速發展，將精湛的技術與科技創新相結合，以滿足不斷變化的臨床需求和患者偏好。本分析概述了醫療設備創新如何重塑市場准入途徑、手術技術如何差異化以及醫療服務模式如何演變，從而為決策者提供策略背景。本報告並未將抽脂手術視為單一類別，而是根據技術、臨床應用領域和最終用戶對市場進行細分，並指出哪些領域的漸進式改進和新進者最有可能影響醫療保健格局。

抽脂醫學的策略轉型是由醫療設備的創新、醫療服務地點的轉變以及對病患​​療效和復健的日益重視所驅動的。

抽脂市場格局正經歷著變革性的轉變，其促進因素包括能量輔助設備的科技進步、門診和診所手術的廣泛接受，以及患者對恢復時間和治療效果日益成長的關注。能量輔助技術的成熟使得組織標靶化和止血更加精準，影響了外科醫師的選擇，並拓展了微創手術的適應症。同時，人體工學、設備便攜性和一次性組件設計的進步，提高了手術效率，並推動了手術模式從以醫院為中心的模式向門診手術中心和專業美容診所的轉變。

美國關稅調整對抽脂設備供應鏈、採購方式和臨床連續性的實際影響。

關稅和貿易措施的實施將對全球醫療設備供應鏈產生重大影響，進而可能影響籌資策略、供應商選擇和價格趨勢。對於在美國運營的製造商和經銷商，關稅調整通常會促使他們重新評估零件採購、契約製造協議和庫存佈局，以降低成本波動風險。在實踐中，受影響的企業通常會透過供應商多元化、加快本地化進程或重新設計物料材料清單(BOM) 來應對，盡可能用國內採購的零件替代受關稅影響的零件。

一種嚴格的細分方法，將醫療設備模式、臨床技術、解剖應用部位、醫療環境和患者人口統計特徵聯繫起來，以指導實踐見解。

一套精細的細分框架揭示了每種模式、技術、解剖目標區域、臨床環境和患者群體在醫療設備的不同趨勢。依類型分類，市場可分為雷射輔助、能量輔助、射頻輔助、抽吸輔助及超音波輔助系統。雷射輔助系統進一步細分為Slimlipo和Smartlipo兩種變體，而超音波輔助系統則以Vaser技術為參考進行分析。這種結構闡明了能量分佈、精確度和溫度控管如何影響臨床應用。基於手術方式，該分析比較了超濕式、傳統式、腫脹麻醉式和濕式抽脂術，揭示了止血、麻醉劑和術中流體動力學之間的權衡。基於應用部位，該分析區分了腹部、手臂、下顎頸部、臀部和大腿手術的臨床實踐，重點突出了解剖結構挑戰、塑形目標和併發症風險方面的差異。基於終端用戶，我們分析了門診手術中心、美容診所和醫院的設備部署模式，揭示了設施限制、認證流程和報銷模式如何影響設備的採購和使用。透過按性別分類女性和男性患者群體，我們有助於解釋美感偏好、組織特徵和季節性需求的差異。結合這些細分觀點，相關人員可以確定在哪些方面投資於培訓、設備功能或定向行銷能夠帶來最大的臨床和商業性回報。

影響抽脂手術受歡迎程度的區域趨勢受到法規差異、文化偏好和醫療基礎設施的影響。

區域趨勢凸顯了管理體制、報銷環境和文化偏好如何影響臨床應用和商業策略。在美洲，主要臨床中心的緊密網路、大規模的美容醫學專業人員群體以及對微創解決方案的重視（優先考慮快速恢復和美觀改善），都影響了創新軌跡。跨境供應鏈關係和區域製造地也影響設備的定位和支援系統。

針對抽脂領域的公司，我們制定了一項競爭策略，將設備創新、臨床教育和綜合服務模式結合，以促進產品的普及和信任。

抽脂領域主要企業正透過產品創新、臨床醫生培訓計畫以及優先考慮安全性和治療效果的綜合服務模式來脫穎而出。主要醫療設備製造商正投資於迭代式設計改進，以增強熱控制、縮短手術時間並簡化使用者介面，從而降低醫療專業人員從傳統技術過渡到新技術的門檻。同時，提供結合術前評估、手術實施和術後監測的綜合護理服務的機構，正在提高患者滿意度並促進重複轉診模式。

針對每種醫療保健環境，提出切實可行的策略建議，以提高醫療保健機構的臨床可靠性、供應鏈韌性和商業化水準。

產業領導者應優先進行一系列合作舉措，以提升臨床可信度、確保供應鏈韌性並擴大其在各類醫療機構中的應用。首先，應投資於全面的臨床證據項目，包括多中心註冊研究和病患報告結局指標（PRO），以支持其在美觀性和安全性方面取得的顯著改善。這一實證基礎將為臨床醫生培訓和與保險公司的諮詢提供支援。其次，應設計可擴展的教育項目，將實踐操作與數位化學習模組結合，以加速從業人員能力的提升，同時降低手術差異性和併發症發生率。

高度透明的混合方法研究途徑，結合臨床文獻、對醫療保健專業人員的訪談和情境分析，產生了實用的見解。

本調查方法結合了系統性的二手文獻綜述、結構化的初次訪談和情境分析，以確保研究結果具有實證依據和實際應用價值。二手資訊包括同行評審的臨床文獻、監管文件和專業學會的程序指南，這些資訊用於建立基準臨床參數和安全考慮。為了補充這些信息，我們還對執業外科醫生、臨床教育工作者、採購負責人和器械工程師進行了初次訪談，以收集有關推廣障礙、培訓需求和供應鏈限制的真實案例。

一項決定性的策略整合，突顯了創新、臨床證據和營運可靠性的交匯點，指導未來的部署。

總之，現代抽脂術的發展趨勢體現在向能量輔助和微創技術的轉變、向門診和診所手術模式的推進，以及市場對可驗證的臨床價值和可靠供應鏈的重視。投資於嚴謹的臨床證據、可擴展的培訓體系和多元化供應鏈的相關人員，將能夠獲得更可預測的推廣效果，並與醫療專業人員建立更牢固的關係。同樣，那些透過上市後監測和治療效果評估來支持臨床醫生，並根據特定解剖結構和手術需求量身定做產品功能的公司，將更有利於確保長期的信任。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：抽脂手術市場：依類型分類

  • 雷射輔助
    • 纖體塑形
    • 智慧型鋰電池
  • 動力輔助型
  • 高頻輔助型
  • 吸力輔助型
  • 超音波輔助
    • Vaser

第9章 抽脂手術市場：依技術分類

  • 超濕潤
  • 傳統方法
  • 膨脹法
  • 濕的

第10章：抽脂手術市場：依應用領域分類

  • 腹部
  • 手臂
  • 下顎和頸部
  • 臀部
  • 大腿

第11章：抽脂手術市場：依最終用戶分類

  • 門診手術中心
  • 美容診所
  • 醫院

第12章 抽脂手術市場：性別

  • 女士
  • 男性

第13章 抽脂手術市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：抽脂手術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：抽脂手術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 美國抽脂手術市場

第17章 中國抽脂手術市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alma Lasers Ltd.
  • Candela Corporation
  • Cutera, Inc.
  • Fotona doo
  • Hologic, Inc.
  • InMode Ltd.
  • Johnson & Johnson
  • Lumenis Ltd.
  • Sciton, Inc.
  • Stryker Corporation
Product Code: MRR-43470FC608C4

The Liposuction Surgical Procedures Market was valued at USD 1.82 billion in 2025 and is projected to grow to USD 1.92 billion in 2026, with a CAGR of 6.73%, reaching USD 2.87 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.82 billion
Estimated Year [2026] USD 1.92 billion
Forecast Year [2032] USD 2.87 billion
CAGR (%) 6.73%

Comprehensive orientation to contemporary liposuction surgical practice that clarifies modalities, clinical drivers, and decision levers for stakeholders

Liposuction procedures continue to evolve rapidly, blending refinements in technique with technological innovation to meet changing clinical expectations and patient preferences. This analysis introduces the strategic context for decision-makers by outlining the interplay of device innovation, procedural technique differentiation, and shifting care delivery models that are reshaping adoption pathways. Rather than treating liposuction as a monolithic category, the report disaggregates the landscape by modality, clinical application area, and end user to reveal where incremental improvements and new entrants are most likely to influence care patterns.

The introduction establishes a clear framework for understanding how procedural efficacy, safety profiles, practitioner training, and consumer demand converge. It emphasizes the importance of longitudinal clinical evidence, the role of minimally invasive adjuncts, and the increasing emphasis on patient experience and aesthetic outcomes. The purpose is to equip clinical leaders, device manufacturers, and strategic investors with a concise orientation that clarifies terminology, distinguishes emerging approaches from legacy practices, and sets expectations for the sections that follow.

Strategic transformation of liposuction care driven by device innovation, site-of-care migration, and an amplified focus on patient outcomes and recovery

The liposuction landscape is undergoing transformative shifts driven by converging forces: technological refinement of energy-assisted devices, broader acceptance of ambulatory and office-based procedures, and heightened patient emphasis on recovery time and visible outcomes. Energy-assisted techniques have matured to provide more precise tissue targeting and hemostasis, thereby influencing surgeon preference and expanding the candidate pool for less invasive interventions. Simultaneously, advances in ergonomics, device portability, and disposable component design are enabling greater procedural throughput and facilitating transitions from hospital-centric models to ambulatory surgical centers and specialized cosmetic clinics.

Regulatory dynamics and evolving clinical guidelines are also reshaping product development priorities, prompting manufacturers to prioritize safety features, standardized training pathways, and real-world evidence generation. Payor perspectives are evolving as well, with clinical utility increasingly scrutinized through the lens of patient-reported outcomes and complication avoidance. As a result, market participation is being redefined by those who can demonstrate differentiating clinical benefits, integrate post-procedural care pathways, and support adoption through structured education and outcome tracking. These shifts create opportunity windows for companies that align product innovation with streamlined care delivery and robust clinician support.

Practical implications of United States tariff adjustments on liposuction device supply chains, procurement behavior, and clinical continuity

The imposition of tariffs and trade measures can create material shocks to global medical device supply chains, influencing procurement strategies, sourcing decisions, and pricing dynamics. For manufacturers and distributors operating within the United States, tariff adjustments often trigger reassessments of component sourcing, contract manufacturing agreements, and inventory positioning to mitigate cost volatility. In practice, affected organizations respond by diversifying supplier bases, accelerating localization efforts, or redesigning product bill-of-materials to substitute tariff-exposed components with domestically sourced alternatives when feasible.

Clinicians and facilities indirectly experience the impact of tariffs through adjustments in device pricing, service contracts, and the availability of consumables. Procurement teams may prioritize vendors with resilient supply chains and transparent cost-management practices. Over time, sustained tariff pressure can incentivize vertically integrated strategies or strategic partnerships that internalize higher-value manufacturing activities to preserve margin and ensure continuity of supply. Equally important, manufacturers that proactively communicate supply chain contingencies and provide clinical support for product transitions tend to retain practitioner trust and minimize disruptions to patient care delivery.

Rigorous segmentation approach linking device modality, clinical technique, anatomical application, care setting, and patient demographics to actionable insights

A nuanced segmentation framework reveals differentiated adoption dynamics across device modality, technique, anatomical target areas, care setting, and patient demographics. Based on Type the market is analyzed across Laser Assisted, Power Assisted, Radio Frequency Assisted, Suction Assisted, and Ultrasound Assisted systems, with Laser Assisted further categorized into Slimlipo and Smartlipo variants and Ultrasound Assisted examined with reference to Vaser technology; this structure clarifies how energy profile, precision, and thermal management drive clinical use cases. Based on Technique liposuction procedures are contrasted across Superwet, Traditional, Tumescent, and Wet approaches to illuminate trade-offs between hemostasis, anesthetic dosing, and intraoperative fluid dynamics. Based on Application Area the analysis differentiates clinical practice across abdomen, arms, chin neck, hips, and thigh procedures to highlight anatomical challenges, contouring goals, and complication risk differentials. Based on End User adoption patterns are dissected across ambulatory surgical centers, cosmetic clinics, and hospitals to show how facility constraints, credentialing processes, and reimbursement models influence procurement and utilization. Based on Gender consideration of female and male patient cohorts helps explain variation in aesthetic priorities, tissue characteristics, and demand seasonality. Together these segmentation lenses enable stakeholders to identify where investments in training, device feature sets, or targeted marketing will deliver the greatest clinical and commercial returns.

Regional dynamics shaping adoption of liposuction procedures driven by regulatory variation, cultural preferences, and differences in care infrastructure

Regional dynamics underscore how regulatory regimes, reimbursement environments, and cultural preferences shape clinical adoption and commercial strategy. In the Americas innovation trajectories are influenced by a dense network of leading clinical centers, a large base of cosmetic practitioners, and an emphasis on minimally invasive solutions that prioritize quick recovery and aesthetic refinement. Cross-border supply chain relationships and regional manufacturing footprints also affect how devices are positioned and supported.

In Europe, Middle East & Africa regulatory harmonization efforts coexist with diverse national health systems, leading manufacturers to adopt flexible market entry and clinical validation pathways that accommodate localized credentialing and training requirements. Cultural preferences for aesthetic norms and the distribution of specialist practitioners influence the mix of procedural application areas and the configuration of support services. In the Asia-Pacific region rapid urbanization, expanding middle-class demand for aesthetic procedures, and growing investment in ambulatory care infrastructure are driving increased procedural volumes and interest in portable, cost-efficient technologies. The diversity of reimbursement practices and clinician training ecosystems across these regions requires tailored commercialization plans that reflect local priorities and operational realities.

Competitive company strategies in liposuction that combine device innovation, clinical education, and integrated service models to drive adoption and trust

Key companies in the liposuction ecosystem are differentiating through product innovation, clinician education programs, and integrated service models that emphasize safety and outcomes. Leading device manufacturers are investing in iterative design improvements that enhance thermal control, reduce procedure time, and simplify user interfaces to lower the barrier to adoption among practitioners transitioning from traditional techniques. Concurrently, providers that offer bundled care services-combining preoperative assessment, procedural execution, and postoperative monitoring-are demonstrating improved patient satisfaction and facilitating repeat referral patterns.

Partnerships between device firms and surgical training organizations are becoming a central strategy to accelerate adoption; manufacturers that offer structured proctoring, simulation-based training, and long-term outcome tracking build clinical confidence more effectively than those relying on transactional sales models. Moreover, companies that align product roadmaps with emerging reimbursement criteria and produce robust real-world evidence to support safety and efficacy claims are better positioned to sustain clinician and payor support. The competitive landscape favors agile firms that integrate clinical insights, responsive service models, and pragmatic supply chain strategies to support consistent product availability and practitioner trust.

Actionable strategic recommendations to fortify clinical credibility, supply chain resilience, and tailored commercialization across care settings

Industry leaders should prioritize a coordinated set of actions that strengthen clinical credibility, secure supply chain resilience, and expand adoption across diverse care settings. First, invest in comprehensive clinical evidence programs that include multi-center registries and patient-reported outcome measures to substantiate claims of improved aesthetic and safety profiles; this empirical foundation supports clinician training efforts and payor discussions. Next, design scalable education pathways that pair hands-on proctoring with digital learning modules to accelerate operator competency while reducing procedural variability and complication rates.

Operationally, diversify supplier relationships and consider nearshoring critical components to mitigate exposure to tariff-related cost disruption. Simultaneously, adopt modular device designs that facilitate component substitution and servicing to preserve uptime in ambulatory contexts. On the commercialization front, tailor value propositions to facility type by emphasizing throughput and cost-per-case for ambulatory surgical centers, streamlined disposable logistics for cosmetic clinics, and compliance and safety features for hospitals. Finally, pursue partnerships with clinical centers of excellence to create reproducible clinical protocols and to serve as demonstration sites for prospective customers. Taken together, these measures create a defensible market position grounded in clinical value and operational reliability.

Transparent mixed-methods research approach integrating clinical literature, practitioner interviews, and scenario analysis to produce actionable insights

The research methodology combines systematic secondary literature review, structured primary interviews, and scenario-based analysis to ensure findings are evidence-based and operationally relevant. Secondary sources included peer-reviewed clinical literature, regulatory filings, and procedural guidance from professional societies to establish baseline clinical parameters and safety considerations. These inputs were complemented by primary interviews with practicing surgeons, clinical educators, procurement specialists, and device engineers to capture real-world insights on adoption barriers, training needs, and supply chain constraints.

Data synthesis employed qualitative coding of interview transcripts to identify recurring themes and to triangulate practitioner-reported experiences with documented clinical outcomes. Scenario analysis was used to explore how alternative policy developments, reimbursement shifts, or technological breakthroughs could plausibly alter adoption pathways. Where applicable, the methodology prioritized transparency in assumptions and clear documentation of inclusion criteria for clinical studies and interview selection to enable readers to assess the robustness of the conclusions and to adapt the findings to their organizational context.

Conclusive strategic synthesis highlighting the intersection of innovation, clinical evidence, and operational reliability that will guide future adoption

In conclusion, the contemporary liposuction landscape is defined by a shift toward energy-assisted and minimally invasive modalities, a migration of procedures to ambulatory and office-based settings, and a marketplace that rewards demonstrable clinical value and reliable supply chains. Stakeholders who invest in rigorous clinical evidence, scalable training infrastructures, and supply chain diversification stand to achieve more predictable adoption outcomes and stronger practitioner relationships. Equally, companies that align product features with specific anatomical and procedural needs, while supporting clinicians through post-market surveillance and outcome measurement, are better positioned to secure long-term credibility.

Decision-makers should view the current environment as an opportunity to re-evaluate product portfolios, prioritize investments that reduce procedural variability, and forge partnerships that accelerate clinician confidence. By focusing on patient safety, measurable outcomes, and operational reliability, manufacturers and providers can collectively elevate standards of care while capturing sustainable commercial benefit. The insights offered in this report are intended to inform those strategic choices and to provide a practical roadmap for translating clinical innovation into routine, high-quality practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Liposuction Surgical Procedures Market, by Type

  • 8.1. Laser Assisted
    • 8.1.1. Slimlipo
    • 8.1.2. Smartlipo
  • 8.2. Power Assisted
  • 8.3. Radio Frequency Assisted
  • 8.4. Suction Assisted
  • 8.5. Ultrasound Assisted
    • 8.5.1. Vaser

9. Liposuction Surgical Procedures Market, by Technique

  • 9.1. Superwet
  • 9.2. Traditional
  • 9.3. Tumescent
  • 9.4. Wet

10. Liposuction Surgical Procedures Market, by Application Area

  • 10.1. Abdomen
  • 10.2. Arms
  • 10.3. Chin Neck
  • 10.4. Hips
  • 10.5. Thigh

11. Liposuction Surgical Procedures Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cosmetic Clinics
  • 11.3. Hospitals

12. Liposuction Surgical Procedures Market, by Gender

  • 12.1. Female
  • 12.2. Male

13. Liposuction Surgical Procedures Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Liposuction Surgical Procedures Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Liposuction Surgical Procedures Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Liposuction Surgical Procedures Market

17. China Liposuction Surgical Procedures Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Alma Lasers Ltd.
  • 18.6. Candela Corporation
  • 18.7. Cutera, Inc.
  • 18.8. Fotona d.o.o.
  • 18.9. Hologic, Inc.
  • 18.10. InMode Ltd.
  • 18.11. Johnson & Johnson
  • 18.12. Lumenis Ltd.
  • 18.13. Sciton, Inc.
  • 18.14. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SLIMLIPO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SLIMLIPO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SLIMLIPO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SMARTLIPO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SMARTLIPO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SMARTLIPO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY POWER ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY POWER ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY POWER ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY RADIO FREQUENCY ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY RADIO FREQUENCY ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY RADIO FREQUENCY ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUCTION ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUCTION ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUCTION ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY VASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY VASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY VASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUPERWET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUPERWET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUPERWET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TUMESCENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TUMESCENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TUMESCENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY WET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY WET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY WET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ABDOMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ABDOMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ABDOMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY CHIN NECK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY CHIN NECK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY CHIN NECK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY HIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY HIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY HIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY THIGH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY THIGH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY THIGH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COSMETIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COSMETIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COSMETIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 149. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 152. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 153. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 155. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GCC LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 173. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 176. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 177. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 179. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. G7 LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 181. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 184. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 185. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 187. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. NATO LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY ULTRASOUND ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA LIPOSUCTION SURGICAL PROCEDURES MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)